Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue
- Conditions
- Nasopharyngeal Carcinoma
- Registration Number
- NCT03048305
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
The investigators collect nasopharyngeal epithelium samples from healthy individuals and analyze for biomarkers compared with tumor tissues from another clinical research project. The goal of this study is to identify molecular biomarkers for prediction of nasopharyngeal carcinoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Patients suspected of nasopharyngeal carcinoma but excluded by biopsy
Exclusion Criteria
- Diagnosed as nasopharyngeal carcinoma during the follow-up period
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the positive rate of risk signature in healthy individuals 3 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are analyzed in NCT03048305 for NPC biomarker identification?
How do NCT03048305 biomarkers compare to EBV DNA in NPC early detection accuracy?
Which specific biomarkers from NCT03048305 predict NPC risk in asymptomatic individuals?
What biomarkers in NCT03048305 correlate with NPC treatment resistance or recurrence?
What targeted therapies could be developed based on NCT03048305 NPC biomarker findings?
Trial Locations
- Locations (1)
Sun Yat-sen University Cancer Center
🇨🇳Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center🇨🇳Guangzhou, Guangdong, ChinaJun Ma, M.D.Principal Investigator